Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026)
Bioventus (BVS) reported Income from Non-Controlling Interests of $833000.0 for Q1 2026, up 221.61% on a YoY basis from $259012.7 in Q1 2025, and down 67.5% quarter-over-quarter from $2.6 million in Q4 2025.
Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Bioventus has reported Income from Non-Controlling Interests for 7 years, with the latest figure at $833000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests rose 221.61% year-over-year to $833000.0; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 651.86% YoY), and the FY2025 full-year result was $4.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $833000.0, down from $2.6 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $18.5 million in Q4 2022, with the low at -$20.4 million in Q2 2023.
- Historically, Income from Non-Controlling Interests has averaged -$765133.3 across 5 years, with a median of -$685000.0 in 2025.
- The largest YoY upside for Income from Non-Controlling Interests was 1312.43% in 2022 against a maximum downside of 764.95% in 2022.
- Bioventus' Income from Non-Controlling Interests stood at $18.5 million in 2022, then tumbled by 108.03% to -$1.5 million in 2023, then surged by 819.69% to $10.7 million in 2024, then plunged by 76.07% to $2.6 million in 2025, then slumped by 67.5% to $833000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at $833000.0 (Q1 2026), $2.6 million (Q4 2025), and $851000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Bioventus | 571.68 Mn | 581.20 Mn | 90.77 Mn | 833,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 833,000.00 |
| Dec 31, 2025 | 2.56 Mn |
| Sep 27, 2025 | 851,000.00 |
| Jun 28, 2025 | 1.81 Mn |
| Mar 29, 2025 | -685,000.00 |
| Dec 31, 2024 | 10.71 Mn |
| Sep 28, 2024 | -683,000.00 |
| Jun 29, 2024 | -8.54 Mn |
| Mar 30, 2024 | -1.49 Mn |
| Sep 30, 2023 | -1.49 Mn |
| Apr 1, 2023 | -20.36 Mn |
| Dec 31, 2022 | 18.54 Mn |
| Oct 1, 2022 | -9.25 Mn |
| Jul 2, 2022 | -762,000.00 |
| Apr 2, 2022 | -3.53 Mn |
| Dec 31, 2021 | -1.53 Mn |
| Oct 2, 2021 | -1.30 Mn |
| Jul 3, 2021 | -6.65 Mn |
| Apr 3, 2021 | -408,000.00 |
| Dec 31, 2020 | -525,000.00 |